MEDI 219-Calcitonin gene-related peptide receptor antagonists for the treatment of migraine

被引:0
|
作者
Williams, Theresa M. [1 ]
Burgey, Christopher S. [1 ]
Paone, Daniel V. [1 ]
Shaw, Anthony W. [1 ]
Bell, Ian M. [1 ]
Deng, James Z. [1 ]
deSolms, Jane [1 ]
Gallicchio, Steven N. [1 ]
Nguyen, Diem N. [1 ]
Potteiger, Craig M. [1 ]
Stump, Craig A. [1 ]
Quigley, Amy G. [1 ]
Theberge, Cory R. [1 ]
Wan, Bang-Lin [1 ]
Zartman, C. Blair [1 ]
Zhang, Xu-Fang [1 ]
Kunapuli, Priya [2 ]
Kane, Stefanie A. [3 ]
Koblan, Ken S. [3 ]
Bednar, Rodney A. [3 ]
Johnston, Victor K. [3 ]
Mallee, John J. [3 ]
Mosser, Scott D. [3 ]
Rutledge, Ruth Z. [3 ]
Salvatore, Christopher [3 ]
McMasters, Daniel R. [4 ]
Hershey, James C. [5 ]
Corcoran, Halea [5 ]
Lyle, Betsy [5 ]
Wong, Bradley
Roller, Shane
Miller-Stein, Cynthia M. [6 ]
Rowe, Janice F. [6 ]
Yu, Sean [6 ]
Graham, Samuel L. [1 ]
Vacca, Joseph P. [1 ]
机构
[1] Merck & Co Inc, Dept Med Chem, West Point, PA 19486 USA
[2] Merck & Co Inc, Automated Biotechnol NW1, West Point, PA 19486 USA
[3] Merck & Co Inc, Pain Res, West Point, PA 19486 USA
[4] Merck & Co Inc, Mol Syst, West Point, PA 19486 USA
[5] Merck & Co Inc, Mol Endocrinol, West Point, PA 19486 USA
[6] Merck & Co Inc, Drug Metab, West Point, PA 19486 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
219-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
    MaassenVandenBrink, Antoinette
    Terwindt, Gisela M.
    van den Maagdenberg, Arn M. J. M.
    GENOME MEDICINE, 2018, 10
  • [22] MEDI 138-Calcitonin gene-related peptide (CGRP) receptor antagonists: Development of the pyridinone series
    Nguyen, Diem N.
    Shaw, Anthony W.
    Paone, Daniel V.
    Burgey, Christopher S.
    Graham, Samuel L.
    Mosser, Scott D.
    Salvatore, Christopher A.
    Leonard, Yvonne M.
    Miller-Stein, Cynthia
    Kane, Stefanie A.
    Koblan, Kenneth S.
    Williams, Theresa M.
    Vacca, Joseph P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [23] Safety and Efficacy of Oral Calcitonin Gene-Related Peptide Receptor Antagonists for the Acute Treatment of Migraine in the Pediatric Population
    Tourlas, K.
    Pavitt, S.
    HEADACHE, 2023, 63 : 166 - 166
  • [24] Safety and Efficacy of Oral Calcitonin Gene-Related Peptide Receptor Antagonists for the Acute Treatment of Migraine in the Pediatric Population
    Tourlas, Konstantinos
    Pavitt, Sara
    NEUROLOGY, 2023, 100 (17)
  • [25] Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
    Antoinette MaassenVanDenBrink
    Gisela M. Terwindt
    Arn M. J. M. van den Maagdenberg
    Genome Medicine, 10
  • [26] Efficacy and safety of calcitonin gene-related peptide antagonists in migraine treatment: A meta-analysis
    Huang, Tingting
    Xu, Yang
    Chen, Yajie
    Bian, Jing
    Chu, Zhaohu
    Zhao, Shoucai
    Ma, Lingsong
    BRAIN AND BEHAVIOR, 2022, 12 (04):
  • [27] Targets for migraine treatment: beyond calcitonin gene-related peptide
    Moreno-Ajona, David
    Villar-Martinez, Maria Dolores
    Goadsby, Peter J.
    CURRENT OPINION IN NEUROLOGY, 2021, 34 (03) : 363 - 372
  • [28] Calcitonin gene-related peptide in migraine: from pathophysiology to treatment
    Santos-Lasaosa, S.
    Belvis, R.
    Cuadradodo, M. L.
    Diaz-Insa, S.
    Gago-Veiga, A.
    Guerrero-Peral, A. L.
    Huerta, M.
    Irimia, P.
    Lainez, J. M.
    Latorre, G.
    Leira, R.
    Pascual, J.
    Porta-Etessam, J.
    Rio, M. Sanchez del
    Viguera, J.
    Pozo-Rosich, y P.
    NEUROLOGIA, 2022, 37 (05): : 390 - 402
  • [29] Update on Calcitonin Gene-Related Peptide Antagonism in the Treatment of Migraine
    Caronna, Edoardo
    Starling, Amaal J.
    NEUROLOGIC CLINICS, 2021, 39 (01) : 1 - 19
  • [30] Telcagepant, a calcitonin gene-related peptide antagonist for the treatment of migraine
    Tepper, Stewart J.
    Cleves, Catalina
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (07) : 711 - 720